unknown
Stage
About
Entasis Therapeutics is a biopharmaceutical company developing antibiotics and adjunctive therapies to treat serious Gram-negative bacterial infections. The company focuses on small-molecule antibacterial agents, including inhibitors aimed at overcoming beta-lactamase–mediated resistance.
Explore Entasis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.